Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-24
DOI
10.1111/jcmm.13860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor microenvironment for cancer stem cells
- (2016) Kazuyoshi Kise et al. ADVANCED DRUG DELIVERY REVIEWS
- Galectin 3 as a guardian of the tumor microenvironment
- (2016) Peter P. Ruvolo BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Colin W. Steele et al. CANCER CELL
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- The β-catenin signaling pathway induces aggressive potential in breast cancer by up-regulating the chemokine CCL5
- (2015) Rika Yasuhara et al. EXPERIMENTAL CELL RESEARCH
- Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
- (2015) Ling-Yen Chung et al. Oncotarget
- CXCL5 Promotes Prostate Cancer Progression
- (2015) Lesa A Begley et al. NEOPLASIA
- Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer
- (2014) C.-S. Huang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
- (2014) Naofumi Mukaida et al. MEDIATORS OF INFLAMMATION
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- The ELR+CXCL chemokines and their receptors CXCR1/CXCR2
- (2014) Sandy Giuliano et al. OncoImmunology
- The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
- (2013) R. Grepin et al. CANCER RESEARCH
- Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
- (2013) B. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
- (2012) L.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Macrophages Promote Fibroblast Growth Factor Receptor-Driven Tumor Cell Migration and Invasion in a Cxcr2-Dependent Manner
- (2012) L. R. Bohrer et al. MOLECULAR CANCER RESEARCH
- Galectin-3 – A jack-of-all-trades in cancer
- (2011) Anna U. Newlaczyl et al. CANCER LETTERS
- Control of senescence by CXCR2 and its ligands
- (2011) Juan C. Acosta et al. CELL CYCLE
- SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells
- (2011) Wei–Lun Hwang et al. GASTROENTEROLOGY
- K-Ras Nanoclustering Is Subverted by Overexpression of the Scaffold Protein Galectin-3
- (2008) R. Shalom-Feuerstein et al. CANCER RESEARCH
- Wnt/β-Catenin and Fgf Signaling Control Collective Cell Migration by Restricting Chemokine Receptor Expression
- (2008) Andy Aman et al. DEVELOPMENTAL CELL
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started